Real-time enrollment status for this moderate to severe psoriatic arthritis clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 3:48 PM UTC
| NCT Number | NCT07801495 |
| Recruiting Status | Recruiting |
| Condition | Moderate to Severe Psoriatic Arthritis |
| Phase | PHASE2 |
| Target Enrollment | 220 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | October 13, 2026 (3 days ago) |
As of October 16, 2026: Clinical trial NCT07801495 is currently recruiting participants. This phase2 study for moderate to severe psoriatic arthritis is actively seeking new participants at 3 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07801495 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07801495 was last updated 3 days ago (October 13, 2026). HelloStudys verifies this status automatically.